Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2010
06/09/2010CN101721474A Externally-applied liniment for treating psoriasis
06/09/2010CN101721469A medicine for treating psoriasis
06/09/2010CN101721463A Chinese medicinal nose mask for removing nose blackheads
06/09/2010CN101721449A Method for preparing lindley eupatorium herb general flavone by using attapulgite adsorption method
06/09/2010CN101721445A Preparation method of vernonia anthelmintica compound silver nanometer colloid
06/09/2010CN101721431A Compound nano pearl starch ball and production process thereof
06/09/2010CN101721373A Solid cefdinir sub-microemulsion and new application thereof
06/09/2010CN101721322A Self tanning compositions containing dihydroxyacetone, a retinoid and ascorbic acid glucoside as a stabilizer
06/09/2010CN101244213B Externally used Chinese medicinal herb for treating decubitus
06/09/2010CN101239163B Medicaments for resisting microwave radiation
06/09/2010CN101234173B Medicament for treating perianal abscess and preparation thereof
06/09/2010CN101230339B Bombina maxima non-crystalline beta gamma-crystallin and trefoil factor protein compound ,gene as well as preparation and use thereof
06/09/2010CN101214326B External medicament for treating acne
06/09/2010CN101199769B External medicament for treating baldness and preparing method thereof
06/09/2010CN101199754B Medicament for treating trauma bleeding, body surface and part cavity film inflammation and preparing method thereof
06/09/2010CN101194923B Novel medicament for treating systematic lupus erythematosus
06/09/2010CN101185748B Traditional Chinese medicine preparation for eliminating naevus and stains
06/09/2010CN101181579B Chrysanthemum row containing natural aromatic plant
06/09/2010CN101181576B Jasmine flower strip containing natural aromatic plant
06/09/2010CN101152491B Alopecia treating medicine, preparing method and uses of the same
06/09/2010CN101130067B Preparation for replenishing collagen and method of preparing the same
06/09/2010CN101099822B Liniment for treating leucoderma
06/09/2010CN101088554B Psoriasis treating Chinese medicine composition and its preparation process
06/09/2010CN101062085B Condyloma acuminata treating medicine
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/09/2010CN101028489B Prescription for treating wart and its production
06/09/2010CN101010076B Immune function-improving agent
06/08/2010US7732655 Controlled release therapeutic wound dressings
06/08/2010US7732610 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732450 Antifungal ketoconazole composition for topical use
06/08/2010US7732442 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
06/08/2010US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
06/08/2010US7732414 cosmetic make-up removing composition; for treating aging, fibroblasts, keratinocytes; particularly hyaluronic acid, proteoglycans
06/08/2010US7731983 Method and composition for the treatment of scars
06/08/2010US7731958 Adjust concentration of interleukins
06/08/2010US7731954 Wound dressings comprising hydrated hydrogels and enzymes
06/08/2010CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2363991C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
06/03/2010WO2010062930A1 Compositions and methods for hyperhidrosis
06/03/2010WO2010062762A2 Compositions and methods for reducing the signs of aging of the skin
06/03/2010WO2010062581A2 A botanical composition for enhanced skin repair and uses thereof
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061931A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
06/03/2010WO2010061915A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061877A1 Mineral absorption improver, and method for improving absorption of minerals
06/03/2010WO2010061185A2 Therapeutic target
06/03/2010WO2010061147A1 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
06/03/2010WO2010060940A2 Hsp90 inhibitors for therapeutic treatment
06/03/2010WO2010060729A1 Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds
06/03/2010WO2010060362A1 Dressing for accelerating wound healing and method of use and manufacture thereof
06/03/2010WO2010060171A1 Moisturizing mixture, cosmetic and/or pharmaceutical compositions containing the moisturizing mixture, use of the moisturizing mixture, and cosmetic method
06/03/2010WO2010007165A3 Treatment of inflammatory diseases with mammal beta defensins
06/03/2010US20100137416 Cadherin-11-mediated modulation of hair growth
06/03/2010US20100137367 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
06/03/2010US20100137364 6-Aminoisoquinoline Compounds
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137260 compound for inhibiting trpv3 function and use thereof
06/03/2010US20100137248 Boron-containing compounds, uses and preparation thereof
06/03/2010US20100137222 Basic Peptides and Their Use as Combined Antibacterial-Antifungine Agents
06/03/2010US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137190 Liquid composition for external application and preparation for external application for treatment of skin ulcer
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136144 Composition containing a quinoa extract for dermatological use
06/03/2010US20100136134 Immune stimulatory infant nutrition
06/03/2010US20100136124 Nanoparticle-coated capsule formulation for dermal drug delivery
06/03/2010US20100136108 Formulation for retinoid-containing soft gelatin capsules
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136091 Methods, systems, and compositions for extracellular matrix production
06/03/2010US20100136068 Dermatological composition for prevention and/or treatment of rosacea, of couperose or of skin which exhibits diffuse redness or small dilated vessels
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135997 Polypeptide monomers and dimers containing mutated ilt
06/03/2010US20100135980 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
06/03/2010US20100135964 Tissue grafting method
06/03/2010US20100135941 Skin-whitening agent
06/03/2010US20100135926 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme
06/03/2010CA2745046A1 Moisturizing mixture, cosmetic and/or pharmaceutical compositions containing the moisturizing mixture, use of the moisturizing mixture, and cosmetic method
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2744857A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug
06/03/2010CA2743722A1 Hsp90 inhibitors for therapeutic treatment
06/03/2010CA2741746A1 Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds
06/02/2010EP2192191A1 Method for production of carotenoid
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2191828A1 Antifungal pharmaceutical composition
06/02/2010EP2191826A1 Pharmaceutical composition
06/02/2010EP2191825A1 Agent for fungal dermatitis
1 ... 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 ... 1065